Summary
Edwards Lifesciences Corporation (EW) filed an 8-K on January 27, 2005, to report its financial results for the fourth quarter and the full year ended December 31, 2004. The report primarily serves to furnish a press release detailing these results, which is attached as Exhibit 99.1. Investors should note that while most of the press release content is furnished and not deemed "filed" under the Exchange Act, specific sections are considered filed, indicating their importance for regulatory and investor scrutiny. This filing is crucial for understanding the company's recent performance and its financial condition leading into the next fiscal year. Investors would be looking to this press release for key metrics such as revenue, profitability, and any forward-looking statements or guidance provided by the company. The 8-K itself confirms the release of this important financial information on the specified date.
Key Highlights
- 1Edwards Lifesciences (EW) filed an 8-K on January 27, 2005.
- 2The filing announces the company's financial results for the fourth quarter and full year 2004.
- 3A press release detailing these financial results is attached as Exhibit 99.1.
- 4The press release contains information deemed 'furnished' and specific sections are considered 'filed' with the SEC.
- 5The filing date of January 27, 2005, indicates the results are for the period ending December 31, 2004.
- 6This report provides investors with an update on the company's financial performance and condition.